世界各国のリアルタイムなデータ・インテリジェンスで皆様をお手伝い

革新的医療の世界市場インサイト、2029年までの予測


Global Innovative Medicine Market Insights, Forecast to 2029

市場分析・洞察：革新的な医薬品の世界市場 革新的医療の世界市場は、2023年の百万米ドルから2029年には百万米ドルに達し、予測期間中の年間平均成長率（CAGR）は％と予測されています。 革新的医療の米国・カ... もっと見る

　

　

出版社 出版年月 電子版価格 言語
QYResearch
QYリサーチ 		2023年5月19日 US$4,900
シングルユーザライセンス
ライセンス・価格情報
注文方法はこちら 		英語

※当ページの内容はウェブ更新時の情報です。
最新版の価格やページ数などの情報についてはお問合せください。
日本語のページは自動翻訳を利用し作成しています。
実際のレポートは英文のみでご納品いたします。


　

サマリー

市場分析・洞察：革新的な医薬品の世界市場
革新的医療の世界市場は、2023年の百万米ドルから2029年には百万米ドルに達し、予測期間中の年間平均成長率（CAGR）は％と予測されています。
革新的医療の米国・カナダ市場は、2023年の100万ドルから2029年には100万ドルに達すると予測され、2023年から2029年までの予測期間中にCAGR %で増加するとされています。
革新的医療の中国市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年までの予測期間中に年平均成長率は %となる見込みです。
革新的医薬品のヨーロッパ市場は、2023年の100万ドルから2029年には100万ドルに達すると推定され、2023年から2029年の予測期間中にCAGR %で増加する。
革新的な医学の世界の主要企業は、ファイザー、ロシュ、サノフィ、ジョンソン＆ジョンソン、メルク＆カンパニー、ノバルティス、AbbVie、Gilead Sciencesとグラクソスミスクラインなど2022年に、世界のトップ5プレーヤーは、収益の面で約％のシェアを持っていた。

レポートの内容
本レポートでは、革新的医療の世界市場規模を概観しています。2018年～2022年の過去の市場収益データ、2023年の予測、2029年までのCAGRの予測など、世界市場動向の分析を行っています。
本レポートでは、Innovative Medicineの主要生産者を調査し、主要地域や国の収益も掲載しています。革新的な医学の今後の市場可能性のハイライト、およびこの市場を様々なセグメントとサブセグメントに予測するための主要な地域/国に焦点を当てます。米国、カナダ、メキシコ、ブラジル、中国、日本、韓国、東南アジア、インド、ドイツ、英国、イタリア、中東、アフリカ、その他諸国の国別データおよび市場価値分析。

本レポートでは、2018年から2023年のデータをもとに、革新的医療の収益、主要企業の市場シェア、業界ランキングに焦点を当てています。世界のInnovative Medicine市場における主要なステークホルダーを特定し、その競争環境と市場ポジショニングを最近の動向とセグメント別の収益に基づき分析します。本レポートは、関係者が競争環境を理解し、より多くの洞察を得て、事業と市場戦略をより良い方法で位置づけるのに役立ちます。
本レポートでは、2018年から2029年までの、タイプ別、用途別のセグメントデータ、収益、成長率を分析しています。革新的な医学の収益、予測される成長動向、生産技術、アプリケーション、エンドユーザー産業の市場規模を評価および予測します。
ファイザー、ロシュ、サノフィ、ジョンソン・エンド・ジョンソン、メルク・アンド・カンパニー、ノバルティス、アッヴィ、ギリアド・サイエンシズ、グラクソ・スミスクラインなど、世界の主要プレイヤーの詳細な会社プロファイル。

会社別
ファイザー
ロシュ
サノフィ
ジョンソン・エンド・ジョンソン
メルク・アンド・カンパニー
ノバルティス
AbbVie
ギリアド・サイエンシズ
グラクソ・スミスクライン
アムジェン
アストラゼネカ
ブリストル・マイヤーズ スクイブ
イーライリリー
バイエル
ノボノルディスク
アラガン
武田薬品工業
ベーリンガーインゲルハイム
タイプ別セグメント
バイオメディスン
ケミカルメディスン
用途別セグメント
オンコロジー
ニューロサイエンス
免疫学
呼吸器
その他
地域別
北アメリカ
米国
カナダ
欧州
ドイツ
フランス
英国
イタリア
ロシア
北欧諸国
その他のヨーロッパ
アジア・パシフィック
中国
日本
韓国
東南アジア
インド
オーストラリア
その他のアジア
中南米
メキシコ
ブラジル
ラテンアメリカの残りの地域
中近東・アフリカ・中南米
トルコ
サウジアラビア
UAE
MEAの残りの地域

各章の概要
第1章：報告書のスコープ、異なる市場セグメント（製品タイプ、アプリケーションなど）のエグゼクティブサマリー、各市場セグメントの市場規模、将来の発展可能性などを紹介します。市場の現状と、短・中期・長期的にどのような進化を遂げる可能性があるのかについて、ハイレベルな視点で解説しています。
第2章 革新的医療の世界・地域レベルでの収益。各地域とその主要国の市場規模と発展可能性を定量的に分析し、世界各国の市場発展、将来の発展見通し、市場スペース、生産能力などを紹介しています。また、市場力学、市場の最新動向、市場の推進要因と制限要因、業界各社が直面する課題とリスク、業界の関連政策の分析などを紹介します。
第3章：革新医療企業の競争環境、収益、市場シェア、業界ランキング、最新の開発計画、M&A情報などを詳細に分析。
第4章：各種市場セグメントをタイプ別に分析し、各市場セグメントの収益、発展可能性を網羅し、読者が異なる市場セグメントにおけるブルーオーシャン市場を見つけるのに役立つ情報を提供する。
第5章：アプリケーション別の様々な市場セグメントの分析を提供し、各市場セグメントの収益、開発可能性をカバーし、読者が異なる下流市場でのブルーオーシャン市場を見つけるのに役立ちます。
第6章：北米：タイプ別、アプリケーション別、国別、各セグメント別の収益。
第7章：ヨーロッパ：タイプ別、アプリケーション別、国別、各セグメントごとの収益。
第8章：中国 タイプ別、アプリケーション別、セグメント別の収益。
第9章：アジア（中国を除く） タイプ別、アプリケーション別、地域別、各セグメントごとの収益。
第10章 中東、アフリカ、中南米 タイプ別、アプリケーション別、国別、各セグメントごとの収益。
第11章：主要企業のプロファイルを提供し、製品の説明や仕様、革新的な医学の収益、粗利益率、最近の開発など、市場の主要企業の基本状況を詳細に紹介する。
第12章 アナリストの視点/結論


ページTOPに戻る


目次

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Innovative Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biological Medicine
1.2.3 Chemical Medicine
1.3 Market by Application
1.3.1 Global Innovative Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Innovative Medicine Market Perspective (2018-2029)
2.2 Global Innovative Medicine Growth Trends by Region
2.2.1 Innovative Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Innovative Medicine Historic Market Size by Region (2018-2023)
2.2.3 Innovative Medicine Forecasted Market Size by Region (2024-2029)
2.3 Innovative Medicine Market Dynamics
2.3.1 Innovative Medicine Industry Trends
2.3.2 Innovative Medicine Market Drivers
2.3.3 Innovative Medicine Market Challenges
2.3.4 Innovative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Innovative Medicine by Players
3.1.1 Global Innovative Medicine Revenue by Players (2018-2023)
3.1.2 Global Innovative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Innovative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Innovative Medicine, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Innovative Medicine Market Concentration Ratio
3.4.1 Global Innovative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Innovative Medicine Revenue in 2022
3.5 Global Key Players of Innovative Medicine Head office and Area Served
3.6 Global Key Players of Innovative Medicine, Product and Application
3.7 Global Key Players of Innovative Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Innovative Medicine Breakdown Data by Type
4.1 Global Innovative Medicine Historic Market Size by Type (2018-2023)
4.2 Global Innovative Medicine Forecasted Market Size by Type (2024-2029)
5 Innovative Medicine Breakdown Data by Application
5.1 Global Innovative Medicine Historic Market Size by Application (2018-2023)
5.2 Global Innovative Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Innovative Medicine Market Size (2018-2029)
6.2 North America Innovative Medicine Market Size by Type
6.2.1 North America Innovative Medicine Market Size by Type (2018-2023)
6.2.2 North America Innovative Medicine Market Size by Type (2024-2029)
6.2.3 North America Innovative Medicine Market Share by Type (2018-2029)
6.3 North America Innovative Medicine Market Size by Application
6.3.1 North America Innovative Medicine Market Size by Application (2018-2023)
6.3.2 North America Innovative Medicine Market Size by Application (2024-2029)
6.3.3 North America Innovative Medicine Market Share by Application (2018-2029)
6.4 North America Innovative Medicine Market Size by Country
6.4.1 North America Innovative Medicine Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Innovative Medicine Market Size by Country (2018-2023)
6.4.3 North America Innovative Medicine Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Innovative Medicine Market Size (2018-2029)
7.2 Europe Innovative Medicine Market Size by Type
7.2.1 Europe Innovative Medicine Market Size by Type (2018-2023)
7.2.2 Europe Innovative Medicine Market Size by Type (2024-2029)
7.2.3 Europe Innovative Medicine Market Share by Type (2018-2029)
7.3 Europe Innovative Medicine Market Size by Application
7.3.1 Europe Innovative Medicine Market Size by Application (2018-2023)
7.3.2 Europe Innovative Medicine Market Size by Application (2024-2029)
7.3.3 Europe Innovative Medicine Market Share by Application (2018-2029)
7.4 Europe Innovative Medicine Market Size by Country
7.4.1 Europe Innovative Medicine Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Innovative Medicine Market Size by Country (2018-2023)
7.4.3 Europe Innovative Medicine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Innovative Medicine Market Size (2018-2029)
8.2 China Innovative Medicine Market Size by Type
8.2.1 China Innovative Medicine Market Size by Type (2018-2023)
8.2.2 China Innovative Medicine Market Size by Type (2024-2029)
8.2.3 China Innovative Medicine Market Share by Type (2018-2029)
8.3 China Innovative Medicine Market Size by Application
8.3.1 China Innovative Medicine Market Size by Application (2018-2023)
8.3.2 China Innovative Medicine Market Size by Application (2024-2029)
8.3.3 China Innovative Medicine Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Innovative Medicine Market Size (2018-2029)
9.2 Asia Innovative Medicine Market Size by Type
9.2.1 Asia Innovative Medicine Market Size by Type (2018-2023)
9.2.2 Asia Innovative Medicine Market Size by Type (2024-2029)
9.2.3 Asia Innovative Medicine Market Share by Type (2018-2029)
9.3 Asia Innovative Medicine Market Size by Application
9.3.1 Asia Innovative Medicine Market Size by Application (2018-2023)
9.3.2 Asia Innovative Medicine Market Size by Application (2024-2029)
9.3.3 Asia Innovative Medicine Market Share by Application (2018-2029)
9.4 Asia Innovative Medicine Market Size by Region
9.4.1 Asia Innovative Medicine Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Innovative Medicine Market Size by Region (2018-2023)
9.4.3 Asia Innovative Medicine Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Innovative Medicine Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Innovative Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Innovative Medicine Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Innovative Medicine Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Innovative Medicine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Innovative Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Innovative Medicine Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Innovative Medicine Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Innovative Medicine Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Innovative Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Innovative Medicine Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Innovative Medicine Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Innovative Medicine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Innovative Medicine Introduction
11.1.4 Pfizer Revenue in Innovative Medicine Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Innovative Medicine Introduction
11.2.4 Roche Revenue in Innovative Medicine Business (2018-2023)
11.2.5 Roche Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Innovative Medicine Introduction
11.3.4 Sanofi Revenue in Innovative Medicine Business (2018-2023)
11.3.5 Sanofi Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Innovative Medicine Introduction
11.4.4 Johnson & Johnson Revenue in Innovative Medicine Business (2018-2023)
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Innovative Medicine Introduction
11.5.4 Merck & Co. Revenue in Innovative Medicine Business (2018-2023)
11.5.5 Merck & Co. Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Innovative Medicine Introduction
11.6.4 Novartis Revenue in Innovative Medicine Business (2018-2023)
11.6.5 Novartis Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Innovative Medicine Introduction
11.7.4 AbbVie Revenue in Innovative Medicine Business (2018-2023)
11.7.5 AbbVie Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Innovative Medicine Introduction
11.8.4 Gilead Sciences Revenue in Innovative Medicine Business (2018-2023)
11.8.5 Gilead Sciences Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Innovative Medicine Introduction
11.9.4 GlaxoSmithKline Revenue in Innovative Medicine Business (2018-2023)
11.9.5 GlaxoSmithKline Recent Developments
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Innovative Medicine Introduction
11.10.4 Amgen Revenue in Innovative Medicine Business (2018-2023)
11.10.5 Amgen Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Innovative Medicine Introduction
11.11.4 AstraZeneca Revenue in Innovative Medicine Business (2018-2023)
11.11.5 AstraZeneca Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Innovative Medicine Introduction
11.12.4 Bristol-Myers Squibb Revenue in Innovative Medicine Business (2018-2023)
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Innovative Medicine Introduction
11.13.4 Eli Lilly Revenue in Innovative Medicine Business (2018-2023)
11.13.5 Eli Lilly Recent Developments
11.14 Bayer
11.14.1 Bayer Company Details
11.14.2 Bayer Business Overview
11.14.3 Bayer Innovative Medicine Introduction
11.14.4 Bayer Revenue in Innovative Medicine Business (2018-2023)
11.14.5 Bayer Recent Developments
11.15 Novo Nordisk
11.15.1 Novo Nordisk Company Details
11.15.2 Novo Nordisk Business Overview
11.15.3 Novo Nordisk Innovative Medicine Introduction
11.15.4 Novo Nordisk Revenue in Innovative Medicine Business (2018-2023)
11.15.5 Novo Nordisk Recent Developments
11.16 Allergan
11.16.1 Allergan Company Details
11.16.2 Allergan Business Overview
11.16.3 Allergan Innovative Medicine Introduction
11.16.4 Allergan Revenue in Innovative Medicine Business (2018-2023)
11.16.5 Allergan Recent Developments
11.17 Takeda
11.17.1 Takeda Company Details
11.17.2 Takeda Business Overview
11.17.3 Takeda Innovative Medicine Introduction
11.17.4 Takeda Revenue in Innovative Medicine Business (2018-2023)
11.17.5 Takeda Recent Developments
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Details
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Innovative Medicine Introduction
11.18.4 Boehringer Ingelheim Revenue in Innovative Medicine Business (2018-2023)
11.18.5 Boehringer Ingelheim Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

　

ページTOPに戻る


　

Summary

Market Analysis and Insights: Global Innovative Medicine Market
The global Innovative Medicine market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Innovative Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Innovative Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The Europe market for Innovative Medicine is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The global key companies of Innovative Medicine include Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co., Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline, etc. in 2022, the global top five players had a share approximately % in terms of revenue.

Report Includes
This report presents an overview of global market for Innovative Medicine market size. Analyses of the global market trends, with historic market revenue data for 2018 - 2022, estimates for 2023, and projections of CAGR through 2029.
This report researches the key producers of Innovative Medicine, also provides the revenue of main regions and countries. Highlights of the upcoming market potential for Innovative Medicine, and key regions/countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Innovative Medicine revenue, market share and industry ranking of main companies, data from 2018 to 2023. Identification of the major stakeholders in the global Innovative Medicine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.
This report analyzes the segments data by type and by application, revenue, and growth rate, from 2018 to 2029. Evaluation and forecast the market size for Innovative Medicine revenue, projected growth trends, production technology, application and end-user industry.
Descriptive company profiles of the major global players, including Pfizer, Roche, Sanofi, Johnson & Johnson, Merck & Co., Novartis, AbbVie, Gilead Sciences and GlaxoSmithKline, etc.

By Company
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co.
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Bayer
Novo Nordisk
Allergan
Takeda
Boehringer Ingelheim
Segment by Type
Biological Medicine
Chemical Medicine
Segment by Application
Oncology
Neurosciences
Immunology
Respiratory
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East, Africa, and Latin America
Turkey
Saudi Arabia
UAE
Rest of MEA

Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Revenue of Innovative Medicine in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. This section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Innovative Medicine companies’ competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: North America by type, by application and by country, revenue for each segment.
Chapter 7: Europe by type, by application and by country, revenue for each segment.
Chapter 8: China by type and by application revenue for each segment.
Chapter 9: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 10: Middle East, Africa, and Latin America by type, by application and by country, revenue for each segment.
Chapter 11: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Innovative Medicine revenue, gross margin, and recent development, etc.
Chapter 12: Analyst's Viewpoints/Conclusions



ページTOPに戻る


Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Innovative Medicine Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
1.2.2 Biological Medicine
1.2.3 Chemical Medicine
1.3 Market by Application
1.3.1 Global Innovative Medicine Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
1.3.2 Oncology
1.3.3 Neurosciences
1.3.4 Immunology
1.3.5 Respiratory
1.3.6 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Innovative Medicine Market Perspective (2018-2029)
2.2 Global Innovative Medicine Growth Trends by Region
2.2.1 Innovative Medicine Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Innovative Medicine Historic Market Size by Region (2018-2023)
2.2.3 Innovative Medicine Forecasted Market Size by Region (2024-2029)
2.3 Innovative Medicine Market Dynamics
2.3.1 Innovative Medicine Industry Trends
2.3.2 Innovative Medicine Market Drivers
2.3.3 Innovative Medicine Market Challenges
2.3.4 Innovative Medicine Market Restraints
3 Competition Landscape by Key Players
3.1 Global Revenue Innovative Medicine by Players
3.1.1 Global Innovative Medicine Revenue by Players (2018-2023)
3.1.2 Global Innovative Medicine Revenue Market Share by Players (2018-2023)
3.2 Global Innovative Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players of Innovative Medicine, Ranking by Revenue, 2021 VS 2022 VS 2023
3.4 Global Innovative Medicine Market Concentration Ratio
3.4.1 Global Innovative Medicine Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Innovative Medicine Revenue in 2022
3.5 Global Key Players of Innovative Medicine Head office and Area Served
3.6 Global Key Players of Innovative Medicine, Product and Application
3.7 Global Key Players of Innovative Medicine, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Innovative Medicine Breakdown Data by Type
4.1 Global Innovative Medicine Historic Market Size by Type (2018-2023)
4.2 Global Innovative Medicine Forecasted Market Size by Type (2024-2029)
5 Innovative Medicine Breakdown Data by Application
5.1 Global Innovative Medicine Historic Market Size by Application (2018-2023)
5.2 Global Innovative Medicine Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Innovative Medicine Market Size (2018-2029)
6.2 North America Innovative Medicine Market Size by Type
6.2.1 North America Innovative Medicine Market Size by Type (2018-2023)
6.2.2 North America Innovative Medicine Market Size by Type (2024-2029)
6.2.3 North America Innovative Medicine Market Share by Type (2018-2029)
6.3 North America Innovative Medicine Market Size by Application
6.3.1 North America Innovative Medicine Market Size by Application (2018-2023)
6.3.2 North America Innovative Medicine Market Size by Application (2024-2029)
6.3.3 North America Innovative Medicine Market Share by Application (2018-2029)
6.4 North America Innovative Medicine Market Size by Country
6.4.1 North America Innovative Medicine Market Size by Country: 2018 VS 2022 VS 2029
6.4.2 North America Innovative Medicine Market Size by Country (2018-2023)
6.4.3 North America Innovative Medicine Market Size by Country (2024-2029)
6.4.4 United States
6.4.5 Canada
7 Europe
7.1 Europe Innovative Medicine Market Size (2018-2029)
7.2 Europe Innovative Medicine Market Size by Type
7.2.1 Europe Innovative Medicine Market Size by Type (2018-2023)
7.2.2 Europe Innovative Medicine Market Size by Type (2024-2029)
7.2.3 Europe Innovative Medicine Market Share by Type (2018-2029)
7.3 Europe Innovative Medicine Market Size by Application
7.3.1 Europe Innovative Medicine Market Size by Application (2018-2023)
7.3.2 Europe Innovative Medicine Market Size by Application (2024-2029)
7.3.3 Europe Innovative Medicine Market Share by Application (2018-2029)
7.4 Europe Innovative Medicine Market Size by Country
7.4.1 Europe Innovative Medicine Market Size by Country: 2018 VS 2022 VS 2029
7.4.2 Europe Innovative Medicine Market Size by Country (2018-2023)
7.4.3 Europe Innovative Medicine Market Size by Country (2024-2029)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 China
8.1 China Innovative Medicine Market Size (2018-2029)
8.2 China Innovative Medicine Market Size by Type
8.2.1 China Innovative Medicine Market Size by Type (2018-2023)
8.2.2 China Innovative Medicine Market Size by Type (2024-2029)
8.2.3 China Innovative Medicine Market Share by Type (2018-2029)
8.3 China Innovative Medicine Market Size by Application
8.3.1 China Innovative Medicine Market Size by Application (2018-2023)
8.3.2 China Innovative Medicine Market Size by Application (2024-2029)
8.3.3 China Innovative Medicine Market Share by Application (2018-2029)
9 Asia (excluding China)
9.1 Asia Innovative Medicine Market Size (2018-2029)
9.2 Asia Innovative Medicine Market Size by Type
9.2.1 Asia Innovative Medicine Market Size by Type (2018-2023)
9.2.2 Asia Innovative Medicine Market Size by Type (2024-2029)
9.2.3 Asia Innovative Medicine Market Share by Type (2018-2029)
9.3 Asia Innovative Medicine Market Size by Application
9.3.1 Asia Innovative Medicine Market Size by Application (2018-2023)
9.3.2 Asia Innovative Medicine Market Size by Application (2024-2029)
9.3.3 Asia Innovative Medicine Market Share by Application (2018-2029)
9.4 Asia Innovative Medicine Market Size by Region
9.4.1 Asia Innovative Medicine Market Size by Region: 2018 VS 2022 VS 2029
9.4.2 Asia Innovative Medicine Market Size by Region (2018-2023)
9.4.3 Asia Innovative Medicine Market Size by Region (2024-2029)
9.4.4 Japan
9.4.5 South Korea
9.4.6 China Taiwan
9.4.7 Southeast Asia
9.4.8 India
9.4.9 Australia
10 Middle East, Africa, and Latin America
10.1 Middle East, Africa, and Latin America Innovative Medicine Market Size (2018-2029)
10.2 Middle East, Africa, and Latin America Innovative Medicine Market Size by Type
10.2.1 Middle East, Africa, and Latin America Innovative Medicine Market Size by Type (2018-2023)
10.2.2 Middle East, Africa, and Latin America Innovative Medicine Market Size by Type (2024-2029)
10.2.3 Middle East, Africa, and Latin America Innovative Medicine Market Share by Type (2018-2029)
10.3 Middle East, Africa, and Latin America Innovative Medicine Market Size by Application
10.3.1 Middle East, Africa, and Latin America Innovative Medicine Market Size by Application (2018-2023)
10.3.2 Middle East, Africa, and Latin America Innovative Medicine Market Size by Application (2024-2029)
10.3.3 Middle East, Africa, and Latin America Innovative Medicine Market Share by Application (2018-2029)
10.4 Middle East, Africa, and Latin America Innovative Medicine Market Size by Country
10.4.1 Middle East, Africa, and Latin America Innovative Medicine Market Size by Country: 2018 VS 2022 VS 2029
10.4.2 Middle East, Africa, and Latin America Innovative Medicine Market Size by Country (2018-2023)
10.4.3 Middle East, Africa, and Latin America Innovative Medicine Market Size by Country (2024-2029)
10.4.4 Brazil
10.4.5 Mexico
10.4.6 Turkey
10.4.7 Saudi Arabia
10.4.8 Israel
10.4.9 GCC Countries
11 Key Players Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Pfizer Business Overview
11.1.3 Pfizer Innovative Medicine Introduction
11.1.4 Pfizer Revenue in Innovative Medicine Business (2018-2023)
11.1.5 Pfizer Recent Developments
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Roche Business Overview
11.2.3 Roche Innovative Medicine Introduction
11.2.4 Roche Revenue in Innovative Medicine Business (2018-2023)
11.2.5 Roche Recent Developments
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Sanofi Business Overview
11.3.3 Sanofi Innovative Medicine Introduction
11.3.4 Sanofi Revenue in Innovative Medicine Business (2018-2023)
11.3.5 Sanofi Recent Developments
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Johnson & Johnson Business Overview
11.4.3 Johnson & Johnson Innovative Medicine Introduction
11.4.4 Johnson & Johnson Revenue in Innovative Medicine Business (2018-2023)
11.4.5 Johnson & Johnson Recent Developments
11.5 Merck & Co.
11.5.1 Merck & Co. Company Details
11.5.2 Merck & Co. Business Overview
11.5.3 Merck & Co. Innovative Medicine Introduction
11.5.4 Merck & Co. Revenue in Innovative Medicine Business (2018-2023)
11.5.5 Merck & Co. Recent Developments
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Novartis Business Overview
11.6.3 Novartis Innovative Medicine Introduction
11.6.4 Novartis Revenue in Innovative Medicine Business (2018-2023)
11.6.5 Novartis Recent Developments
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 AbbVie Business Overview
11.7.3 AbbVie Innovative Medicine Introduction
11.7.4 AbbVie Revenue in Innovative Medicine Business (2018-2023)
11.7.5 AbbVie Recent Developments
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Gilead Sciences Business Overview
11.8.3 Gilead Sciences Innovative Medicine Introduction
11.8.4 Gilead Sciences Revenue in Innovative Medicine Business (2018-2023)
11.8.5 Gilead Sciences Recent Developments
11.9 GlaxoSmithKline
11.9.1 GlaxoSmithKline Company Details
11.9.2 GlaxoSmithKline Business Overview
11.9.3 GlaxoSmithKline Innovative Medicine Introduction
11.9.4 GlaxoSmithKline Revenue in Innovative Medicine Business (2018-2023)
11.9.5 GlaxoSmithKline Recent Developments
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Amgen Business Overview
11.10.3 Amgen Innovative Medicine Introduction
11.10.4 Amgen Revenue in Innovative Medicine Business (2018-2023)
11.10.5 Amgen Recent Developments
11.11 AstraZeneca
11.11.1 AstraZeneca Company Details
11.11.2 AstraZeneca Business Overview
11.11.3 AstraZeneca Innovative Medicine Introduction
11.11.4 AstraZeneca Revenue in Innovative Medicine Business (2018-2023)
11.11.5 AstraZeneca Recent Developments
11.12 Bristol-Myers Squibb
11.12.1 Bristol-Myers Squibb Company Details
11.12.2 Bristol-Myers Squibb Business Overview
11.12.3 Bristol-Myers Squibb Innovative Medicine Introduction
11.12.4 Bristol-Myers Squibb Revenue in Innovative Medicine Business (2018-2023)
11.12.5 Bristol-Myers Squibb Recent Developments
11.13 Eli Lilly
11.13.1 Eli Lilly Company Details
11.13.2 Eli Lilly Business Overview
11.13.3 Eli Lilly Innovative Medicine Introduction
11.13.4 Eli Lilly Revenue in Innovative Medicine Business (2018-2023)
11.13.5 Eli Lilly Recent Developments
11.14 Bayer
11.14.1 Bayer Company Details
11.14.2 Bayer Business Overview
11.14.3 Bayer Innovative Medicine Introduction
11.14.4 Bayer Revenue in Innovative Medicine Business (2018-2023)
11.14.5 Bayer Recent Developments
11.15 Novo Nordisk
11.15.1 Novo Nordisk Company Details
11.15.2 Novo Nordisk Business Overview
11.15.3 Novo Nordisk Innovative Medicine Introduction
11.15.4 Novo Nordisk Revenue in Innovative Medicine Business (2018-2023)
11.15.5 Novo Nordisk Recent Developments
11.16 Allergan
11.16.1 Allergan Company Details
11.16.2 Allergan Business Overview
11.16.3 Allergan Innovative Medicine Introduction
11.16.4 Allergan Revenue in Innovative Medicine Business (2018-2023)
11.16.5 Allergan Recent Developments
11.17 Takeda
11.17.1 Takeda Company Details
11.17.2 Takeda Business Overview
11.17.3 Takeda Innovative Medicine Introduction
11.17.4 Takeda Revenue in Innovative Medicine Business (2018-2023)
11.17.5 Takeda Recent Developments
11.18 Boehringer Ingelheim
11.18.1 Boehringer Ingelheim Company Details
11.18.2 Boehringer Ingelheim Business Overview
11.18.3 Boehringer Ingelheim Innovative Medicine Introduction
11.18.4 Boehringer Ingelheim Revenue in Innovative Medicine Business (2018-2023)
11.18.5 Boehringer Ingelheim Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

　

ページTOPに戻る

ご注文は、お電話またはWEBから承ります。お見積もりの作成もお気軽にご相談ください。

webからのご注文・お問合せはこちらのフォームから承ります

本レポートと同分野（医療/ヘルスケア）の最新刊レポート

QYResearch社の医薬・ヘルスケア分野での最新刊レポート

本レポートと同じKEY WORD（medicine）の最新刊レポート


よくあるご質問


QYResearch社はどのような調査会社ですか?


QYリサーチ(QYResearch)は幅広い市場を対象に調査・レポート出版を行う、中国に本社をおく調査会社です。   QYResearchでは年間数百タイトルの調査レポートを出版しています。... もっと見る


調査レポートの納品までの日数はどの程度ですか?


在庫のあるものは速納となりますが、平均的には 3-４日と見て下さい。
但し、一部の調査レポートでは、発注を受けた段階で内容更新をして納品をする場合もあります。
発注をする前のお問合せをお願いします。


注文の手続きはどのようになっていますか?


1)お客様からの御問い合わせをいただきます。
2)見積書やサンプルの提示をいたします。
3)お客様指定、もしくは弊社の発注書をメール添付にて発送してください。
4)データリソース社からレポート発行元の調査会社へ納品手配します。
5) 調査会社からお客様へ納品されます。最近は、pdfにてのメール納品が大半です。


お支払方法の方法はどのようになっていますか?


納品と同時にデータリソース社よりお客様へ請求書（必要に応じて納品書も）を発送いたします。
お客様よりデータリソース社へ（通常は円払い）の御振り込みをお願いします。
請求書は、納品日の日付で発行しますので、翌月最終営業日までの当社指定口座への振込みをお願いします。振込み手数料は御社負担にてお願いします。
お客様の御支払い条件が60日以上の場合は御相談ください。
尚、初めてのお取引先や個人の場合、前払いをお願いすることもあります。ご了承のほど、お願いします。


データリソース社はどのような会社ですか?


当社は、世界各国の主要調査会社・レポート出版社と提携し、世界各国の市場調査レポートや技術動向レポートなどを日本国内の企業・公官庁及び教育研究機関に提供しております。
世界各国の「市場・技術・法規制などの」実情を調査・収集される時には、データリソース社にご相談ください。
お客様の御要望にあったデータや情報を抽出する為のレポート紹介や調査のアドバイスも致します。



詳細検索

このレポートへのお問合せ

お問合せはこちらから

03-3582-2531

電話お問合せもお気軽に

 

2024/12/23　10:26

157.72 円

164.94 円

201.11 円

ページTOPに戻る

株式会社 データリソース　Data Resources, Inc.
東京都港区赤坂1-14-5　アークヒルズエグゼクティブタワー N313

電話：03-3582-2531
FAX：03-3582-2861
Eメール：office@dri.co.jp

FAQ サイトマップ プライバシーポリシー お問合せ

関連会社:
株式会社ユーディーアール

COPYRIGHT(C) 2011-2023　DATA RESOURCES, Inc. ALL RIGHTS RESERVED.